Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mycophenolic Acid Versus Azathioprine as Primary Immunosuppression for Kidney Transplant Recipients." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/repview. Accessed 27 April 2024.
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/repview. Accessed April 27, 2024.
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/repview
Mycophenolic Acid Versus Azathioprine as Primary Immunosuppression for Kidney Transplant Recipients [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
ID - 432810
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -